Comparative effectiveness of pemafibrate versus bezafibrate on hepatic and vascular endothelial function in patients with coronary artery disease and metabolic dysfunction-associated steatotic liver disease.
Saved in:
| Title: | Comparative effectiveness of pemafibrate versus bezafibrate on hepatic and vascular endothelial function in patients with coronary artery disease and metabolic dysfunction-associated steatotic liver disease. |
|---|---|
| Authors: | Nakamura A; Department of Cardiology, Iwate Prefectural Central Hospital, Morioka, Japan., Kagaya Y; Department of Cardiology, Iwate Prefectural Central Hospital, Morioka, Japan., Saito H; Department of Cardiology, Iwate Prefectural Central Hospital, Morioka, Japan., Kanazawa M; Department of Cardiology, Iwate Prefectural Central Hospital, Morioka, Japan., Miura M; Department of Cardiology, Iwate Prefectural Central Hospital, Morioka, Japan., Kondo M; Department of Cardiology, Iwate Prefectural Central Hospital, Morioka, Japan., Endo H; Department of Cardiology, Iwate Prefectural Central Hospital, Morioka, Japan. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 Feb 11; Vol. 17, pp. 1750308. Date of Electronic Publication: 2026 Feb 11 (Print Publication: 2026). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Comparative Study |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
